Kestra Medical Technologies, Ltd.
KMTS
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $1.5B
$25.54
▲ +1.59%
P/E
-10.55
Mkt Cap
$1.5B
52-Wk Range
$16.68–$30.00
52-Week Range
$16.68 - $30.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 43.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
3 reasons
- Integrated platform combining device, digital health, and patient support in single solution
- Proprietary wearable technology with intuitive design reducing patient burden
- Comprehensive data analytics enabling personalized patient monitoring and intervention
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Strong growth ahead
Expanding addressable market for wearable cardiac monitoring devices
Value
Trading at 0.0x Medical Devices peers — a discount despite the growth profile.
Momentum
Hot
+31.6% over 3m
Quality
Strong
High-growth business (59% revenue growth, 51% gross margin). Pre-profit but investing in growth.
Dividend
None
No dividend
Smart-money signal
Who's buying KMTS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 14, 2026
JUL 14, 2026
Reported EPS of -$0.67 vs -$0.59 consensus (-13.6% surprise). Revenue of $28.6M vs $26.5M expected (+8.2%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-13.6%
Revenue trend · last 8Q
—
—
+82%
+71%
+52%
+53%
+63%
+66%
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
Q4 26
$12.8M
$14.7M
$15.1M
$17.2M
$19.4M
$22.6M
$24.6M
$28.6M
Margins · last 8Q
Gross
54.8%
Operating
-137.4%
Profit
-135.6%
Wall Street consensus
3 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
—
Latest: Oppenheimer · Jul 21, 2026
vs Industry
How KMTS stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related